Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Abstract: Limited data exist comparing haploidentical and mismatched unrelated donor (MMUD) hematopoietic cell transplantation (HCT) with posttransplantation cyclophosphamide for graft-versus-host disease prophylaxis, especially considering donor age. Herein, we report the outcomes of 660 haploident...
Saved in:
| Main Authors: | Yosra M. Aljawai, Jeremy Ramdial, Gabriela Rondon, Portia Smallbone, Partow Kebriaei, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925003349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
by: Anna Maria Raiola, et al.
Published: (2025-04-01) -
GVHD PROPHYLAXIS WITH METHOTREXATE IN HAPLOIDENTICAL HCT USING POSTTRANSPLANT CYCLOPHOSPHAMIDE: A PHASE IB/II CLINICAL TRIAL (NCT04622956)
by: G Fatobene, et al.
Published: (2024-10-01) -
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
by: Betül Oran, et al.
Published: (2025-07-01) -
Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
by: Scott R. Solomon, et al.
Published: (2016-01-01) -
Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01)